Dong-A ST Donates Pharmaceuticals to Cambodia

Dong-A ST has donated prescription drugs worth 150 million won ($107,142) to aid medically vulnerable groups in Cambodia. The pharmaceuticals were delivered to Hebron Medical Center in Phnom Penh on November 10. This donation is part of a consistent contribution program initiated in 2018, with this year's support being more substantial than previous years. A local distributor also contributed financially this year, following a beverage donation the previous year.

Beyond simply providing pharmaceuticals, Dong-A ST is offering technical support using advanced medical devices. The company's HiCardi program, a wearable patient monitoring platform, assists in improving the efficiency of patient management by local medical staff. HiCardi, which is attached to a patient’s body to continuously measure biosignals such as electrocardiogram data, enables medical staff to monitor patients' conditions in real time.

In 2025, Dong-A ST has committed to a five-year agreement with Hebron Medical Center, providing HiCardi Plus and Live Studio devices worth approximately 100 million won ($71,428). This year, which marks the second year of support, the company conducted training for local medical staff on device installation and operation. This groundwork ensures stable use of the devices in medical settings.

Hebron Medical Center, initially established as a free clinic in 2007 by Kim Woo-jung, Director of Medical Center, has evolved into a non-profit hospital treating 90,000 low-income patients annually. The support from Dong-A ST will primarily benefit patients in urgent need of treatment, as determined by local medical staff.